Protalix Biotherapeutics Inc (PLX)
SG&A Expense Growth
1.97%
Quarterly · Period ending:
PLX SG&A Expense Growth
Latest reported1.97%period ending
Latest reported1.97%period ending
PLX Quarterly SG&A Growth (QoQ) (0.00% → 1.97%)
Latest values, visible window
High-resolution chart · PNG
PLX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -38.5319% | |
| -51.9622% | |
| 1,314.5829% | |
| -79.9848% | |
| 14.1185% | |
| -30.2777% | |
| -77.0138% | |
| -2.6011% | |
| -22.5817% | |
| -79.7784% | |
| 49.1979% | |
| 24.6667% | |
| 689.4737% | |
| 0% | |
| -5% | |
| 42.8571% | |
| 40% | |
| 400% | |
| 100% | |
| 0% |